NCT05819684View on ClinicalTrials.gov

A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

April 18, 2023

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

SHR-4602 for injection

be administered via intravenous (IV) infusion

Trial Locations (1)

510120

RECRUITING

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY